Actively Recruiting
Genomics and COVID-19 Vaccine Adverse Events
Led by University of British Columbia · Updated on 2026-05-01
6325
Participants Needed
1
Research Sites
231 weeks
Total Duration
On this page
Sponsors
U
University of British Columbia
Lead Sponsor
C
Centers for Disease Control and Prevention
Collaborating Sponsor
AI-Summary
What this Trial Is About
Vaccines routinely used are extremely safe; however, severe adverse events to vaccines do occur. As vaccination against COVID-19 has begun, adverse events to the vaccine, particularly Guillain-Barré syndrome (GBS), vaccine-induced immune thrombotic thrombocytopenia (VITT)/thrombosis with thrombocytopenia syndrome (TTS), and myocarditis/pericarditis, after COVID-19 vaccination have been reported worldwide. Study hypothesis: there are genetic factors that contribute to increased risks of particular COVID-19 vaccine-induced adverse events. The objective of the study is to determine if there are specific genetic factors strongly associated with each of the COVID-19 vaccine-induced adverse events (i.e., GBS, VITT/TTS, and myocarditis/pericarditis).
CONDITIONS
Official Title
Genomics and COVID-19 Vaccine Adverse Events
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who received COVID-19 vaccines and developed Guillain-Barr�e9 syndrome (GBS), vaccine-induced immune thrombotic thrombocytopenia (VITT)/thrombosis with thrombocytopenia syndrome (TTS), or myocarditis/pericarditis after vaccination
- Participants who received COVID-19 vaccines and did not experience GBS, VITT/TTS, or myocarditis/pericarditis
You will not qualify if you...
- Individuals who have not received a COVID-19 vaccine
- Individuals unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
British Columbia Children's Hospital Research Institute
Vancouver, British Columbia, Canada, V5Z 4H4
Actively Recruiting
Research Team
B
Bruce Carleton, PharmD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here